Differential expression of the semaphorin 3A pathway in prostatic cancer

Histopathology

Volumn 55, Issue 4, 2009, Pages 392-398

  Yacoub, Mokrane ^b   Coulon, Alix ^b   Celhay, Olivier ^c   Irani, Jacques ^d   Cussenot, Olivier ^a,d   Fromont, Gaelle ^a,b,e  

^a CeRePP   (France)

^b Department of Pathology ^*  (France)

^c UNIVERSITÉ DE POITIERS   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e University of Poitiers   (France)

Author keywords

Immunohistochemistry; Prostatic cancer; RT PCR; Semaphorin 3; Tissue array analysis

Indexed keywords

SEMAPHORIN 3A;

ADULT; AGED; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY;

AGED; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUROPILIN-1; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SEMAPHORIN-3A; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70349921322     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03406.x     Document Type: Article

References (18)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000: the global picture. Eur. J. Cancer 2001 37 S4 S66.
2. Stearn ME, McGarvey T. Biology of disease: prostate cancer: therapeutics, diagnostic and basic studies. Lab. Invest. 1992 67 540 552.
3. Kolodkin AL, Matthes DJ, Goodman CS. The semaphoring genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 1993 75 217 227.
4. Goshima Y, Ito T, Sasaki Y, Nakamura F. Semaphorins as signals for cell repulsion and invasion. J. Clin. Invest. 2002 109 993 998.
5. Chedotal A, Kerjan G, Moreau-Faurvaque C. The brain within the tumor: new roles for axon guidance molecules in cancers. Cell Death Differ. 2005 12 1044 1056.
6. Castellani V, Rougon V. Control of semaphoring signalling. Curr. Opin. Neurobiol. 2002 12 532 541.
7. Bagnard D, Sainturet N, Meyronet D et al. Differential MAP kinases activation during Sema3A induced repulsion or apoptosis of neural progenitor cells. Mol. Cell. Neurosci. 2004 25 722 731.
8. Bachelder RE, Lipscomb EA, Lin X et al. Competing autocrin pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res. 2003 63 5230 5233.
9. Miao HQ, Soker S, Feiner L, Alonso JL, Raper JA, Klagsbrun M. Neuropilin-1 mediates collapsing-1/semaphoring III inhibition of endothelial cell mobility: functional competition of collapsing-1 and vascular endothelial growth factor-165. J. Cell Biol. 1999 146 233 242.
10. Latil A, Bièche I, Pesche S et al. VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms. Int. J. Cancer 2000 89 169 171.
11. Fromont G, Chene L, Vidaud M et al. Differential expression of 37 selected genes in hormone-refractory prostate cancer using quantitative taqman real-time RT-PCR. Int. J. Cancer 2005 114 174 181.
12. Vacca A, Scavelli C, Serini G et al. Loss of inhibitory Sema3A autocrine loops in bone marrow endothelial cells of patients with multiple myeloma. Blood 2006 108 1661 1667.
13. Jackson MW, Roberts JS, Heckford SE et al. A potential autocrine role for vascular endothelial growth factor in prostate cancer. Cancer Res. 2002 62 854 859.
14. Brambilla E, Constantin B, Drabkin H, Roche J. Semaphorin 3F localization in malignant lung and cell lines. Am. J. Pathol. 2000 156 939 950.
15. Lantuéjoul S, Constantin B, Drabkin H, Brambilla C, Roche J, Brambilla E. Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines. J. Pathol. 2003 200 336 347.
16. Osada R, Horiuchi A, Kikuchi N et al. Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas. Hum. Pathol. 2006 37 1414 1425.
17. Hansel DE, Wilentz RE, Yeo CJ, Schulick RD, Montgomery E, Maitra A. Expression of neuropilin 1 in high grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract. Am. J. Surg. Pathol. 2004 28 347 356.
18. Catalano A, Caprari P, Rodilossi S et al. Cross-talk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation. FASEB J. 2004 18 358 360.